Proxygen Names Chiara Conti Chief Scientific Officer
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Proxygen hired Chiara Conti as chief scientific officer, with the Pharmalot column noting she previously served as senior director at Blueprint Medicines.
- Ed Silverman's 'Up and down the ladder' column is a regular feature tracking comings and goings across the pharmaceutical industry, with the full roster of moves gated behind a STAT+ paywall.
Why it matters: The column offers a snapshot of executive movement across drugmakers, useful for tracking talent flow between established pharma companies and smaller biotechs; the Conti move illustrates the pipeline of senior R&D leaders moving from mid-cap players like Blueprint into emerging biotechs like Proxygen.